Today, CDC announced the release of more than 77,000 additional doses of Beyfortus(TM) (nirsevimab-alip (100 mg), a long-acting monoclonal antibody designed to protect infants against severe respiratory syncytial virus (RSV) disease.
Today, CDC announced the release of more than 77,000 additional doses of Beyfortus(TM) (nirsevimab-alip (100 mg), a long-acting monoclonal antibody designed to protect infants against severe respiratory syncytial virus (RSV) disease.
CDC and FDA will host a telephone-only media availability to discuss information about the multi-state investigation of meningitis among patients who have received epidural steroid injections.
CDC and FDA will host a telephone-only media availability to discuss information about the multi-state investigation of meningitis among patients who have received epidural steroid injections.
CDC and FDA hosted a telephone-only media availability to discuss information about the multi-state investigation of meningitis among patients who have received epidural steroid injections.
CDC and FDA hosted a telephone-only media availability to discuss information about the multi-state investigation of meningitis among patients who have received epidural steroid injections.